
Utility of Monitoring H3.1 Plasma Concentrations as a Surrogate of Treatment Response and Remission in Dogs with Cancer
- Share
- Tweet
- Share on Facebook
- Share


Poster titled: ‘Utility of Monitoring H3.1 Plasma Concentrations as a Surrogate of Treatment Response and Remission in Dogs with Cancer’.
Presented at: World Veterinary Cancer Congress 2024, Tokyo 2024
Dr Heather Wilson-Robles et al
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields